These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 16792829)

  • 1. Neonatal haemoglobinopathy screening: review of a 10-year programme in Brussels.
    Gulbis B; Ferster A; Cotton F; Lebouchard MP; Cochaux P; Vertongen F
    J Med Screen; 2006; 13(2):76-8. PubMed ID: 16792829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neonatal haemoglobinopathy screening in Belgium.
    Gulbis B; Cotton F; Ferster A; Ketelslegers O; Dresse MF; Rongé-Collard E; Minon JM; Lé PQ; Vertongen F
    J Clin Pathol; 2009 Jan; 62(1):49-52. PubMed ID: 19103861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Newborn screening for haemoglobinopathies: the Brussels experience.
    Gulbis B; Tshilolo L; Cotton F; Lin C; Vertongen F
    J Med Screen; 1999; 6(1):11-5. PubMed ID: 10321364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neonatal haemoglobinopathy screening in Burkina Faso.
    Kafando E; Nacoulma E; Ouattara Y; Ayéroué J; Cotton F; Sawadogo M; Gulbis B
    J Clin Pathol; 2009 Jan; 62(1):39-41. PubMed ID: 19103858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of haemoglobinopathies detected through neonatal screening in the United Arab Emirates.
    Al Hosani H; Salah M; Osman HM; Farag HM; Anvery SM
    East Mediterr Health J; 2005 May; 11(3):300-7. PubMed ID: 16602448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Starting neonatal screening for haemoglobinopathies in The Netherlands.
    Giordano PC
    J Clin Pathol; 2009 Jan; 62(1):18-21. PubMed ID: 19103852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neonatal/newborn haemoglobinopathy screening in Europe and Africa.
    Bain BJ
    J Clin Pathol; 2009 Jan; 62(1):53-6. PubMed ID: 19103862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neonatal screening for hemoglobinopathies in the Brussels region].
    Tshilolo L; Gulbis B; Barlow P; Damis E; Denis-Song R; Ferster A; Haumont D; Vanderpas JB; Pardou A; Schwers J; Vokaer A; Vertongen F
    Rev Med Brux; 1997 Apr; 18(2):70-3. PubMed ID: 9221465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Universal newborn screening for haemoglobinopathies in Guadeloupe (French West Indies): a 27-year experience.
    Saint-Martin C; Romana M; Bibrac A; Brudey K; Tarer V; Divialle-Doumdo L; Petras M; Keclard-Christophe L; Lamothe S; Broquere C; Etienne-Julan M
    J Med Screen; 2013 Dec; 20(4):177-82. PubMed ID: 24144845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemoglobinopathies and newborn haemoglobinopathy screening in Germany.
    Dickerhoff R; Genzel-Boroviczeny O; Kohne E
    J Clin Pathol; 2009 Jan; 62(1):34. PubMed ID: 19103856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for haemoglobinopathies on cord blood: laboratory and clinical experience.
    Wolff F; Cotton F; Gulbis B
    J Med Screen; 2012 Sep; 19(3):116-22. PubMed ID: 23093729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential of electrospray ionization mass spectrometry for the diagnosis of hemoglobin variants found in newborn screening.
    Wild BJ; Green BN; Stephens AD
    Blood Cells Mol Dis; 2004; 33(3):308-17. PubMed ID: 15528150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Newborn screening for sickle cell disease: effect on mortality.
    Vichinsky E; Hurst D; Earles A; Kleman K; Lubin B
    Pediatrics; 1988 Jun; 81(6):749-55. PubMed ID: 3368274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neonatal screening for sickle cell disorders in Ouagadougou, Burkina Faso: a pilot study.
    Kafando E; Sawadogo M; Cotton F; Vertongen F; Gulbis B
    J Med Screen; 2005; 12(3):112-4. PubMed ID: 16156939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation of the newborn screening programme for sickle cell disease in England: results for 2003-2005.
    Streetly A; Clarke M; Downing M; Farrar L; Foo Y; Hall K; Kemp H; Newbold J; Walsh P; Yates J; Henthorn J
    J Med Screen; 2008; 15(1):9-13. PubMed ID: 18416948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Newborn bloodspot results: predictive value of screen positive test for thalassaemia major.
    Streetly A; Latinovic R; Henthorn J; Daniel Y; Dormandy E; Darbyshire P; Mantio D; Fraser L; Farrar L; Will A; Tetlow L
    J Med Screen; 2013 Dec; 20(4):183-7. PubMed ID: 24277229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neonatal screening for sickle cell disease in France.
    Bardakdjian-Michau J; Bahuau M; Hurtrel D; Godart C; Riou J; Mathis M; Goossens M; Badens C; Ducrocq R; Elion J; Perini JM
    J Clin Pathol; 2009 Jan; 62(1):31-3. PubMed ID: 19103855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal screening for sickle cell anaemia in the Democratic Republic of the Congo: experience from a pioneer project on 31 204 newborns.
    Tshilolo L; Aissi LM; Lukusa D; Kinsiama C; Wembonyama S; Gulbis B; Vertongen F
    J Clin Pathol; 2009 Jan; 62(1):35-8. PubMed ID: 19103857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neonatal screening and clinical care programmes for sickle cell disorders in sub-Saharan Africa: lessons from pilot studies.
    Tshilolo L; Kafando E; Sawadogo M; Cotton F; Vertongen F; Ferster A; Gulbis B
    Public Health; 2008 Sep; 122(9):933-41. PubMed ID: 18555498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Genetic carrier screening for hemoglobinopathies in the Netherlands is not opportune].
    Schulpen TW; van der Lee JH; van der Most van Spijk MW; Beemer FA
    Ned Tijdschr Geneeskd; 1998 May; 142(18):1019-22. PubMed ID: 9623203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.